Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Rule 2.10 Announcement

13 Jun 2006 15:54

Cambridge Antibody Tech Group PLC13 June 2006 ANNOUNCEMENT FOR IMMEDIATE RELEASE 13 June 2006 CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC ("CAT") RULE 2.10 ANNOUNCEMENT CAT announces, in accordance with Rule 2.10 of the City Code on Takeovers andMergers, that subsequent to an issue of 200 ordinary shares under the CATCompany Share Option Plan (OSCSOPO), its issued share capital as at 13 June2006 comprises 53,206,393 ordinary shares of 10p each (including thoserepresented by American Depositary Shares) ("CAT Shares"). The ISIN reference number for the CAT Shares is GB0001662252 and for theAmerican Depositary Shares of CAT is US1321481079. Enquiries: Justin Hoskins (Company Secretary), CAT Tel: +44 (0) 1223 741 741 END This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.